Daclizumab for children with corticosteroid refractory graft-versus-host disease.

Teachey, D T; Bickert, B; Bunin, N

Teachey, D T; Bickert, B; Bunin, N.

Affiliation

Teachey DT; Division of Oncology in the Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. teacheyd@email.chop.edu

Bone Marrow Transplant ; 37(1): 95-9, 2006 Jan.

Article in En | MEDLINE | ID: mdl-16247417

Subject(s)

Antibodies, Monoclonal/administration & dosage; Graft vs Host Disease/drug therapy; Hematologic Diseases/therapy; Immunoglobulin G/administration & dosage; Immunosuppressive Agents/administration & dosage; Stem Cell Transplantation; Acute Disease; Adolescent; Adrenal Cortex Hormones/therapeutic use; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Chronic Disease; Daclizumab; Disease-Free Survival; Drug Resistance/drug effects; Female; Graft vs Host Disease/mortality; Hematologic Diseases/complications; Hematologic Diseases/metabolism; Humans; Infant; Male; Recurrence; Remission Induction; Transplantation, Homologous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Stem Cell Transplantation / Graft vs Host Disease / Hematologic Diseases / Immunosuppressive Agents / Antibodies, Monoclonal Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2006 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links